Back

Angiotensin-converting enzyme inhibitors for aortic stenosis: a drug-target mendelian randomisation study

1 September 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Aortic stenosis genesis Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jonathan Ciofani

University of Sydney, Sydney (Australia)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Y. Zhang (Bonn, DE)
Abstract Slides
Presentation thumbnail
Mr R. Chudy (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Doctor E. Koljonen (Kuopio, FI)
Abstract
Presentation thumbnail
Doctor R. Jamin (Bonn, DE)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Aortic stenosis genesis

The Event

Event poster

ESC Congress 2025

1 September 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
RAAS inhibitors in patients undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry
thumbnail
Congress Presentation
Sex-specific drug-target Mendelian randomisation on the effects of lipid-modifying targets on cardiovascular disease
thumbnail
Congress Presentation
Hypertension in thoracic aortic aneurysm and dissection: considerations in the choice of antihypertensive agents for the long-term management

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources